Priothera
Biotech · Dublin, IE
Dublin biotech developing S1P receptor modulators for blood and bone-marrow cancers.
Funding history
| Date | Round | Amount |
|---|
| Oct 2020 | Series A Dublin leukemia biotech Priothera raised a EUR30M Series A round led by Fountain Healthcare Partners. | $35M |
Investors
Earlybird Venture CapitalFountain Healthcare PartnersHealthCapTekla Capital Management
Similar companies in Biotech
Explore funding flow on EquityFlow →